Welcome to the Second Edition of the Global Psoriasis Atlas


Our research indicates that there are more than 60 million people living with psoriasis globally.


Psoriasis is a systemic disease that affects people physically and psychologically and is associated with other important medical conditions.


One of the aims of the GPA is to understand the number of people around the world who have psoriasis and the care and treatment available to them.


Explore and share the Global Psoriasis Atlas and join us in our efforts to ensure that people are provided with the best available data on psoriasis globally.

Click on the blue dots to see GPA Coordinators from around the world

Greenland

In May 2022, the GPA team conducted a pilot study on skin diseases among adults in Tasiilaq on the East coast of Greenland with Professor Jacob P. Thyssen, Professor Claus Zachariae and team from The University of Copenhagen. This work was published in the International Journal of Circumpolar Health in 2024.

See prevalence data for Greenland
Next to Denmark

Denmark

Following on from a systematic review and meta-analysis of the association of psoriasis and risk of cancer, published in JAMA Dermatology in 2021, the GPA collaborated with Professor Alexander Egeberg to conduct new population-based epidemiological studies in Denmark, Israel, Taiwan and the United Kingdom exploring cancer incidence and cancer mortality in people with psoriasis. The GPA research team are also working on quantifying the use of healthcare resources in people with psoriasis, and associated costs to the healthcare system, to provide novel insights into the impact of psoriasis on health and well-being, and productivity at work in Denmark.

See prevalence data for Denmark
Next to Myanmar

Myanmar

The GPA team continue to work with Dr Su Lwin to provide educational support in Myanmar, in conjunction with the International Psoriasis Council, and to facilitate discussions on a future large-scale epidemiological skin disease survey.

See prevalence data for Myanmar
Next to Taiwan

Taiwan

The GPA research team completed a study examining changes in the prevalence, incidence and mortality rates in people with psoriasis or psoriatic arthritis in Taiwan. These findings were published in Acta Dermato-Venereologica in 2022. The team also completed a study using the national claims database from Taiwan examining the risks of serious infection in people with psoriasis. This research was published in the Journal of the European Academy of Dermatology and Venereology in 2023.

See prevalence data for Taiwan
Next to Malaysia

Malaysia

The GPA worked closely with Professor Siew Eng Choon to examine the incidence and prevalence of psoriasis in Malaysia. This is the first time that data was reported on the epidemiology of psoriasis in Southeast Asia. This work was published in the British Journal of Dermatology in 2022. The GPA research team continued to work with Professor Choon examining the incidence and prevalence of generalised pustular psoriasis (GPP) in Malaysia. The prevalence of GPP was estimated to be 198 per million, marking the highest national prevalence recorded to date. This work was published in the British Journal of Dermatology in 2023.

See prevalence data for Malaysia
Next to Chile

Chile

The GPA team collaborated on work led by Dr Cristóbal Lecaros and Dr Claudia De la Cruz to examine the incidence of psoriasis in Chile. This work provided the first incidence data on psoriasis in the country and was published in Clinical and Experimental Dermatology. in 2021.

See prevalence data for Chile
Next to Newfoundland

Newfoundland

The GPA has collaborated on work led by Professor Wayne Gulliver to examine the incidence and prevalence of psoriasis in the Newfoundland and Labrador population. The group is working on the preparation of abstracts for international dermatology meetings in 2025.

See prevalence data for Canada
Next to Brazil

Brazil

The GPA team have been involved in several publications in Brazil. In 2023 with GPA Regional Coordinator Professor Ricardo Romiti the team examined the prevalence of psoriasis and other autoimmune skin diseases in a recently contacted Amerindian community in the Auaris region, Yanomami territory, Brazil, and in 2024 the GPA were involved in the publication of a paper on the epidemiology of atopic dermatitis and psoriasis in the indigenous people of Brazil. Most recently the GPA team worked with IPC Fellow Dr Jaquelini Barboza da Silva on a cross-sectional survey of the experience of living with psoriasis in Brazil. This paper was published in the International Journal of Dermatology in 2024.

See prevalence data for Brazil
Next to Tanzania

Tanzania

In 2019 the GPA team performed a skin disease survey of the Maasai in North Eastern Tanzania. Results of this survey concluded that the prevalence of psoriasis may well be close to the estimate for the country of less than 1%. In 2023 a paper looking at skin disease amongst Maasai adults and potential barriers to accessing dermatological care was published in the British Journal of Dermatology.

See prevalence data for Tanzania
Next to United Kingdom

United Kingdom

The GPA have been involved in several publications in the UK. In 2022 Dr Maha Abo-Tabik, former GPA PhD graduate, undertook research mapping opportunities for the earlier diagnosis of psoriasis in primary care settings in the UK. This research was published in the British Journal of General Practice in 2022. In 2023 Dr Teng-Chou Chen, former GPA Research Associate, conducted research into the Fertility Trends and Adverse Pregnancy Outcomes in Female Patients with Psoriasis in the UK. This research was published in JAMA Dermatology in 2023. In 2024 the GPA team were involved in the publication of a study investigating the prevalence of multiple long‐term conditions with psoriasis in England in the Journal of the European Academy of Dermatology and Venereology. The GPA research team will be undertaking several new studies in 2025, in collaboration with the Psoriasis Association UK, updating estimates of the epidemiology of psoriasis and GPP in the UK and exploring variations by ethnicity.

See prevalence data for United Kingdom
Next to Afghanistan

Afghanistan

The GPA team worked with Dr Ahmad Aalemi in 2024 researching the prevalence of anxiety and depression symptoms among patients with psoriasis in Kabul, Afghanistan. Results of this research were published in the International Journal of Dermatology in 2024.

See prevalence data for Afghanistan
Next to South Africa

South Africa

In December 2023, the GPA team conducted the first-ever cross-sectional point-prevalence study of skin disease in South Africa (Eastern Cape) collaborating with GPA Regional Coordinator Professor Ncoza Dlova and team from The University of KwaZulu-Natal (UKZN). The team are working on a paper for publication in the British Journal and Dermatology.

See prevalence data for South Africa
Next to Philippines

Philippines

In 2024 the GPA team hosted IPC Fellow Dr Bryan Guevara, a dermatologist from the Southern Philippines. Dr Guevara is currently working with the GPA research team on a survey examining the burden of psoriasis experienced by people in the Philippines. Data from this survey is being analysed with a view to publishing later in 2025.

See prevalence data for Philippines
End

Latest GPA Articles

a c

PUSTULAR PSORIASIS RESEARCH PROGRESS

 

Psoriasis is a chronic, immune-mediated inflammatory disease that affects at least 60 million people worldwide. 

 

 

 

Read more

 

alison

INTRODUCING ALISON WRIGHT

 

Research Associate, Dr Alison Wright, joined the GPA team in January 2021 with plans to extend our work programme by improving our understanding of multi-morbidity in people with psoriasis.

 

 

Read more

 

3

ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE

 

The Global Psoriasis Atlas (GPA) team are excited to announce the launch of our newly designed website. We wanted to create a site that is faster, easier to navigate and more user-friendly.

 

Read more

 

Annual Report

April 2024 - March 2025

April 2023 - March 2024

April 2022 - March 2023

April 2021 - March 2022